Syngenta announced today that it has agreed to acquire biotech company Pasteuria Bioscience (Alachua, FL) for $86 million. Syngenta and Pasteuria have had an exclusive global technology partnership since 2011 to develop and commercialize biological products to control plant-parasitic nematodes, using the naturally occurring soil bacteria Pasteuria spp. The companies say they will use an in-vitro production process to develop costeffective nematicides with a novel mode of action. The first product will be a seed treatment for soybean cyst nematode to be launched in the U.S. in 2014.
展开▼
